Stocks-NVO-Novo-Nordisk A/S SPONS ADR

NVO Novo-Nordisk A/S SPONS ADR

137.31 -1.47 (-1.06%)
Delayed Prices By NASDAQ, in USD Market Open
Invest
Stocks-NVO-Novo-Nordisk A/S SPONS ADR
NVO Novo-Nordisk A/S SPONS ADR
Invest

Overview

Prev Close138.78
Day's Range 137.14 - 139.90
52 Week Range 94.33 - 141.27
Average Volume (3M)1.41M
1-Year Return34.29%
Beta0.551
Market Cap236.74B
P/E Ratio41.11
Revenue24.3B
EPS3.3756
Dividend (Yield)1.138123 (0.83%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.718/08/202231/10/202212/01/2023100.00110.00120.00130.00140.00150.00
Chart times in UTC
Sector
Health Technology
Industry Pharmaceuticals Major
CEO Lars Fruergaard Jørgensen, MBA
Employees 47,792

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Novo-Nordisk A/S SPONS ADR's revenues increased by 15.27% and amounted to 22.38B. Net income increased by 17.79% to 7.59B. Net assets increased by 3.92% to 10.82B and EPS increased from 2.75 to 3.30.
NVO's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
84.18%
Net Profit Margin
33.54%
Operating Margin
41.79%
Return On Investment
66.32%
12/21
03/22
06/22
09/22
Total Revenue
5.89B
6.34B
5.9B
6.17B
Gross Profit
4.93B
5.29B
5.04B
5.19B
Operating Income
2.1B
2.83B
2.61B
2.72B
Net Income
1.67B
2.14B
1.91B
1.95B